Compounds for enzyme inhibition

Details for Australian Patent Application No. 2005243168 (hide)

Owner Proteolix, Inc.

Inventors Bunin, Barry A.; Shenk, Kevin D.; Musser, John H.; Borchardt, Ronald T.; Laidig, Guy J.; Radel, Peggy A.; Crews, Craig M.; Smyth, Mark S.

Agent Shelston IP

Pub. Number AU-B-2005243168

PCT Pub. Number WO2005/111008

Priority 60/634,366 07.12.04 US; 60/610,040 14.09.04 US; 60/569,885 10.05.04 US

Filing date 9 May 2005

Wipo publication date 24 November 2005

Acceptance publication date 23 February 2012

International Classifications

C07K 5/087 (2006.01) Peptides having up to four amino acids in a fully defined sequence

A61K 31/335 (2006.01) - having oxygen as the only ring hetero atom, e.g. fungichromin

A61K 38/06 (2006.01) Medicinal preparations containing peptides - Tripeptides

C07D 303/32 (2006.01) Compounds containing three-membered rings having one oxygen atom as the only ring hetero atom

C07D 409/12 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms

C07D 413/12 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms

C07K 5/027 (2006.01) Peptides having up to four amino acids in a fully defined sequence

C07K 5/06 (2006.01) Peptides having up to four amino acids in a fully defined sequence

C07K 5/062 (2006.01) Peptides having up to four amino acids in a fully defined sequence

C07K 5/078 (2006.01) Peptides having up to four amino acids in a fully defined sequence

C07K 5/08 (2006.01) Peptides having up to four amino acids in a fully defined sequence

Event Publications

30 November 2006 PCT application entered the National Phase

  PCT publication WO2005/111008 Priority application(s): WO2005/111008

23 February 2012 Application Accepted

  Published as AU-B-2005243168

21 June 2012 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005243169-Porcine Forssman synthetase protein, cDNA, genomic organization, and regulatory region

2005243161-Compositions, kit and one-step method for monitoring compounds having antifactor Xa and/or anti factor iia activities